| Literature DB >> 32804200 |
Robert Cohen1,2,3,4,5, Corinne Levy1,2,4,5, Naim Ouldali1,2,6, Marie Goldrey7, Stéphane Béchet1, Stéphane Bonacorsi8,9, Emmanuelle Varon2,10.
Abstract
We aimed to assess the invasive disease potential of non-PCV13 serotypes after the implementation of this vaccine. Most non-PCV13 serotypes had low invasive disease potential. Among serotypes with the highest invasive disease potential (12F, 24F, 38, 8, 33F, 22F, and 10A), all but 24F and 38 were included in PCV20.Entities:
Keywords: 13 valent pneumococcal conjugate vaccine; children; invasive disease potential; pneumococci
Mesh:
Substances:
Year: 2021 PMID: 32804200 DOI: 10.1093/cid/ciaa917
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079